` EXENS (Exosens SAS) vs DAX Index Comparison - Alpha Spread

E
EXENS
vs
D
DAX Index

Over the past 12 months, EXENS has significantly outperformed DAX Index, delivering a return of +84% compared to the DAX Index's 2% drop.

Stocks Performance
EXENS vs DAX Index

Loading
EXENS
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
EXENS vs DAX Index

Loading
EXENS
DAX Index
Difference
www.alphaspread.com

Performance By Year
EXENS vs DAX Index

Loading
EXENS
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Exosens SAS vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Exosens SAS
Glance View

Market Cap
3.2B EUR
Industry
N/A

Exosens SAS is a FR-based company operating in industry. The company is headquartered in Merignac, Nouvelle-Aquitaine. The company went IPO on 2024-06-07. EXOSENS SAS is a France-based company which is a manufacturer and seller of technologies in the field of particles and photo detection and imaging intended to serve space, research, defense and commercial clients. The firm designs, produces and markets electro-optic components and devices including sensors and optics for the detection and amplification of low light, radiation, and emissions. The company offers detectors and detection solutions: such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes to respond to complex issues in environment.

EXENS Intrinsic Value
Not Available
E
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett